Doximity 对比 HealthStream

可添加、更换或移除公司，最多四家。

简而言之

Doximity 规模更大:2026 财年营收 $645M，HealthStream 为 $304M，约为后者的 2.1 倍。
Doximity 营收增长更快(13.1%，对方为 4.3%)。
Doximity 每一美元销售额中留下的营业利润更多(营业利润率 33.3%，对方为 6.7%)。
Doximity 将更多销售额转化为自由现金流(自由现金流利润率 50.6%，对方为 19.6%)。
投资者愿为 HealthStream 每一美元的盈利支付更高价格：市盈率 48.8x，而 Doximity 为 39.3x。

最近财年	DOCS · FY26	HSTM · FY25
规模
市值	$6.4B	$1.0B
营收	$645M	$304M
自由现金流	$326M	$59.6M
净利润	$196M	$18.3M
增长
营收增长	13.1%	4.3%
5年增长率	25.5%	4.4%
股数变化	−1.1%	−1.3%
盈利能力
毛利率	89.1%	—
营业利润率	33.3%	6.7%
净利率	30.4%	6.0%
自由现金流利润率	50.6%	19.6%
资本回报率	91.3%	—
股本回报率	19.3%	5.1%
资产负债表
净债务	−$749M	—
净债务 / EBITDA	−3.3x	—
股息与回购	$432M	$33.7M
估值与质量
市盈率	39.3x	48.8x
Piotroski F 分数	4	—

营收

FY17

DOCS —

HSTM $215M

FY18

DOCS —

HSTM $232M

FY19

DOCS —

HSTM $254M

FY20

DOCS $116M

HSTM $245M

FY21

DOCS $207M

HSTM $257M

FY22

DOCS $344M

HSTM $267M

FY23

DOCS $419M

HSTM $279M

FY24

DOCS $475M

HSTM $292M

FY25

DOCS $570M

HSTM $304M

FY26

DOCS $645M

HSTM —

FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25 FY26

DOCS HSTM

营业利润率

FY17

DOCS —

HSTM 4.4%

FY18

DOCS —

HSTM 6.7%

FY19

DOCS —

HSTM 5.8%

FY20

DOCS 19.0%

HSTM 6.5%

FY21

DOCS 25.8%

HSTM 3.1%

FY22

DOCS 33.1%

HSTM 4.7%

FY23

DOCS 29.9%

HSTM 5.7%

FY24

DOCS 34.5%

HSTM 7.3%

FY25

DOCS 39.9%

HSTM 6.7%

FY26

DOCS 33.3%

HSTM —

FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25 FY26

DOCS HSTM

自由现金流

FY17

DOCS —

HSTM $41.2M

FY18

DOCS —

HSTM $36.1M

FY19

DOCS —

HSTM $43.7M

FY20

DOCS $25.9M

HSTM $33.9M

FY21

DOCS $82.7M

HSTM $39.0M

FY22

DOCS $125M

HSTM $49.4M

FY23

DOCS $178M

HSTM $61.8M

FY24

DOCS $184M

HSTM $56.3M

FY25

DOCS $273M

HSTM $59.6M

FY26

DOCS $326M

HSTM —

FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25 FY26

DOCS HSTM

资本回报率

FY17

DOCS —

HSTM —

FY18

DOCS —

HSTM —

FY19

DOCS —

HSTM —

FY20

DOCS —

HSTM —

FY21

DOCS —

HSTM —

FY22

DOCS —

HSTM —

FY23

DOCS 64.8%

HSTM —

FY24

DOCS 88.4%

HSTM —

FY25

DOCS 126.3%

HSTM —

FY26

DOCS 91.3%

HSTM —

FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25 FY26

DOCS HSTM

各公司最近一个财年的数据；各公司财年结束月份不同。在越高(或越低)明显越好的行中，突出显示最佳值。不构成投资建议。